Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Tarceva

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Tarceva was produced by Roche and Astellas.

NICE recommends tests to detect lung cancer mutation

NICE recommends tests to detect lung cancer mutation These include Boehringer Ingelheim's Giotrif/ Gilotrif (afatinib) and Roche's Tarceva (erlotinib), both of which have specific approvals for use in patients with EGFR. ... Both medicines were also approved by the US Food and Drug Administration (FDA)

Intellectual property threats in the BRIC markets

Intellectual property threats in the BRIC markets of the compulsory licence process for Herceptin, Sprycel and Ixempra, revocation of a patent for Pfizer's Sutent and a legal ruling allowing a generic version of Tarceva.

Boehringer breaks into oncology with FDA approval

Boehringer breaks into oncology with FDA approval Roche and Astellas also received fast-track status in January for their cancer drug Tarceva to cover first-line treatment of NSCLC, receiving approval for this expanded indication in March. ... Like Tarceva (erlotinib),  Gilotrif is also an EGFR

NICE knocks back Lilly’s Alimta in new setting

NICE knocks back Lilly’s Alimta in new setting In June 2011 the Institute rejected Roche's NSCLC drug Tarceva in a maintenance setting because of uncertainty over how long it is able to extend survival.

Interview: Kay Drake and Naoki Okamura, Astellas

Interview: Kay Drake and Naoki Okamura, Astellas The company has also out-licensed a non-small cell lung cancer treatment (Tarceva) and non-Hodgkin's lymphoma treatment (bendamustine) to its strategic partners, with several prospective new oncology medications

[ Previous 5 results ] 9 10 11 12 13 14 15 16 17 18 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

The era of digital wellbeing
Social media - friend or foe?...
World Mental Health Day 2019: Employment and Mental Illness
Mednet Group's white paper with a focus on navigating the world of work is available online in aid of World Mental Health Day 2019....
Changing direction
Changing direction: adapting to a rapidly-evolving environment
Chris Ross examines why creative partnerships could be key to commercial success in today’s healthcare marketplace...

Infographics